Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine-abusing outpatients wearing nicotine or placebo patches
- PMID: 15943543
- DOI: 10.1037/1064-1297.13.2.102
Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine-abusing outpatients wearing nicotine or placebo patches
Abstract
In a 2-week intervention to reduce cigarette smoking among outpatients in treatment for cocaine addiction, 20 subjects were randomly assigned to a contingent group, receiving monetary vouchers for breath samples with carbon monoxide (CO) levels of 8 ppm or less, or to a noncontingent group, receiving vouchers regardless of CO level. Subjects wore either nicotine or placebo patches in a randomized crossover design. Contingent subjects had significantly lower CO levels and met the 8 ppm target significantly more often than did noncontingent subjects; however, number of cigarettes reported smoked did not differ between groups. Use of nicotine patches resulted in CO levels significantly lower than did use of placebo patches, but levels still exceeded 8 ppm regardless of type of patch. Because contingent reward helped cocaine-dependent smokers achieve nonsmoking CO targets, behavioral antismoking interventions merit continued study in similar populations.
Copyright 2005 APA, all rights reserved.
Similar articles
-
Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.Psychopharmacology (Berl). 2002 Nov;164(2):177-87. doi: 10.1007/s00213-002-1176-1. Epub 2002 Aug 27. Psychopharmacology (Berl). 2002. PMID: 12404080 Clinical Trial.
-
Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.Clin Ther. 2008 Oct;30(10):1852-8. doi: 10.1016/j.clinthera.2008.09.016. Clin Ther. 2008. PMID: 19014840 Clinical Trial.
-
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.J Pharmacol Exp Ther. 1998 Dec;287(3):958-62. J Pharmacol Exp Ther. 1998. PMID: 9864279 Clinical Trial.
-
Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?Nicotine Tob Res. 2007 Nov;9(11):1139-46. doi: 10.1080/14622200701684172. Nicotine Tob Res. 2007. PMID: 17978987 Clinical Trial.
-
[Alternative method of smoking cessation--reduce to stop].Przegl Lek. 2006;63(10):1108-10. Przegl Lek. 2006. PMID: 17288230 Review. Polish.
Cited by
-
Incentives for smoking cessation.Cochrane Database Syst Rev. 2019 Jul 17;7(7):CD004307. doi: 10.1002/14651858.CD004307.pub6. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2025 Jan 13;1:CD004307. doi: 10.1002/14651858.CD004307.pub7. PMID: 31313293 Free PMC article. Updated.
-
Incentives for smoking cessation.Cochrane Database Syst Rev. 2025 Jan 13;1(1):CD004307. doi: 10.1002/14651858.CD004307.pub7. Cochrane Database Syst Rev. 2025. PMID: 39799985
-
Nicotine replacement therapy versus control for smoking cessation.Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5. Cochrane Database Syst Rev. 2018. PMID: 29852054 Free PMC article.
-
Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement.Psychopharmacology (Berl). 2007 Mar;190(4):485-96. doi: 10.1007/s00213-006-0627-5. Epub 2007 Jan 5. Psychopharmacology (Berl). 2007. PMID: 17205320 Clinical Trial.
-
Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.J Subst Abuse Treat. 2017 Jan;72:10-18. doi: 10.1016/j.jsat.2016.09.008. Epub 2016 Sep 28. J Subst Abuse Treat. 2017. PMID: 27746057 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous